Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 10, 2025

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …

SPS Commerce Announces Date of First Quarter 2025 Financial Results
MINNEAPOLIS, April 10, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that it will issue its financial results for the first quarter ended March 31, 2025, after the market close …

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …

AvePoint to Announce First Quarter 2025 Financial Results on May 8
JERSEY CITY, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- AvePoint (NASDAQ: AVPT), the global leader in data security, governance, and resilience, will report its first quarter 2025 financial results after the US financial markets close on Thursday, May 8, …

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …

Astera Labs Announces Conference Call to Review First Quarter 2025 Financial Results
SANTA CLARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the …

Varonis Announces Date of First Quarter 2025 Financial Results
MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced that it will report its first quarter 2025 financial results following the close of the U.S. financial markets Tuesday, May 6, 2025. In …

Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …

AppFolio, Inc. Announces Date of First Quarter 2025 Financial Results Conference Call
SANTA BARBARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its first quarter 2025 financial results after the close of the U.S. financial markets on Thursday, April 24, 2025. In conjunction …

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the …

374Water Announces Settlement of Claim
DURHAM, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology for municipal, federal, and industrial markets, today announced that it has reached a …

Geekvape Wenax M Starter Kit Wins Prestigious 2025 Red Dot Design Award
Shenzhen, China, April 10, 2025 (GLOBE NEWSWIRE) -- Geekvape, a global leader in vaping technology and innovation, proudly announces that its Wenax M Starter Kit has been honored with the 2025 Red Dot Design Award, one of the most prestigious international …

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …

Mode launches AI-native perpetuals DEX powered by Orderly
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Mode, an AI-focused Ethereum Layer 2 focused on user growth and composability, has launched Mode Trade, its native perpetuals DEX, powered by Orderly’s unified trading infrastructure. This marks the first time a …

سمارت موبيليتي إنترناشونال توقّع اتفاقية شراكة مع IM Motors لدولة الإمارات والسعودية
أبرمت سمارت موبيليتي إنترناشونال شراكة إستراتيجية مع IM Motors لإطلاق سيارات كهربائية فاخرة في كل من دولة الإمارات والمملكة العربية السعودية، مع IM LS7 SUV. DUBAI, UNITED ARAB EMIRATES, April 10, 2025 /EINPresswire.com/ -- أعلنت شركة سمارت موبيليتي …

Theriva Biologics anuncia la presentación de los datos del ensayo clínico de fase 1b/2a de SYN-004 (ribaxamasa) en receptores de trasplantes alogénicos de células hematopoyéticas
ROCKVILLE, Maryland, April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), («Theriva» o la «Empresa»), una empresa diversificada de fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en …

EXL Schedules First Quarter 2025 Financial Results Conference Call
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the first quarter ended March 31, 2025, on Tuesday, April 29, 2025, after the market closes. An earnings …

Intersec Achieves Red Hat OpenShift Certifications
Red Hat OpenShift Certifications Enhances the Reliability, Security, and Scalability of the cloud-native Intersec products for Telecoms and Governments. PARIS, FRANCE, April 10, 2025 /EINPresswire.com/ -- Paris, April 10, 2025 – Intersec, leading …